Blue Harbour Group - Q3 2020 holdings

$0 is the total value of Blue Harbour Group's 0 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .

 Value Shares↓ Weighting
New00$00
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-10-14
Signatures

The EDGAR filing(s) were signed by:

About Blue Harbour Group

Blue Harbour Group is a well-known investment firm that specializes in active ownership of publicly traded companies. The firm was founded in 2004 by Clifton Robbins, who serves as the CEO and Chief Investment Officer. Robbins has over 30 years of experience in the finance industry and is widely respected for his expertise in value investing.

Blue Harbour Group has a team of experienced professionals who work closely with management teams and boards of directors to create long-term value for shareholders. The firm's investment strategy is focused on identifying undervalued companies with strong fundamentals and working with management to unlock their full potential.

One of the key strengths of Blue Harbour Group is its ability to engage with companies in a constructive and collaborative manner. The firm has a reputation for being a trusted partner to management teams and boards, and its approach has led to successful outcomes for both the firm and its portfolio companies.

Blue Harbour Group has a diverse portfolio of investments across a range of industries, including healthcare, technology, and consumer goods. Some of the firm's notable investments include Hologic, a leading provider of diagnostic and surgical products for women's health, and Encompass Health, a provider of post-acute healthcare services.

Overall, Blue Harbour Group is a respected investment firm with a proven track record of creating value for its investors. With a talented team of professionals and a disciplined investment approach, the firm is well-positioned for continued success in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INVESTORS BANCORP INC NEW21Q3 201919.4%
ALLSCRIPTS HEALTHCARE SOLUTN20Q1 20188.1%
ISHARES TR18Q4 20185.2%
Rowan Companies PLC-A17Q1 20189.7%
XILINX INC16Q4 201815.6%
OPEN TEXT CORP14Q2 202021.5%
AKAMAI TECHNOLOGIES INC14Q1 201712.4%
AGCO CORP14Q3 201713.2%
SPDR S&P 500 ETF TR14Q3 20183.8%
ADIENT PLC13Q1 202018.3%

View Blue Harbour Group's complete holdings history.

Latest significant ownerships (13-D/G)
Blue Harbour Group Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Adient plcMay 06, 20204,166,1404.4%
WESCO INTERNATIONAL INCJanuary 15, 20202,068,3844.9%
Investors Bancorp, Inc.Sold outDecember 18, 201900.0%
JACK IN THE BOX INC /NEW/May 21, 2019299,8511.2%
ROWAN COMPANIES PLCJanuary 10, 20185,809,8004.6%
WebMD Health Corp.August 24, 20172,658,1667.1%
BWX Technologies, Inc.June 09, 20171,992,8292.0%
AGCO CORP /DEFebruary 23, 20173,854,4004.8%
Babcock & Wilcox Enterprises, Inc.Sold outJanuary 10, 201700.0%
RACKSPACE HOSTING, INC.October 20, 20166,067,2004.8%

View Blue Harbour Group's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2020-10-14
13F-HR2020-07-31
13F-HR2020-05-15
SC 13D/A2020-05-06
13F-HR2020-02-14
SC 13D/A2020-01-15
SC 13D/A2019-12-18
13F-HR2019-11-14
13F-HR2019-08-14
SC 13D/A2019-05-21

View Blue Harbour Group's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported number of holdings is incorrect (0 != 1)

Export Blue Harbour Group's holdings